Patients with Alzheimer’s disease (AD) have lower levels of the neuromodulator acetylcholine (ACh) in their brains. Donepezil, an AD drug, increases brain ACh levels and…
Researchers from DZNE and Ulm University Hospital have identified a protein in the blood that may indicate the degradation of neural connections years before the…
Late-life dementia is becoming increasingly common in people after 80 years of age.
A study investigating the role of Treponema denticola (T. denticola) in Alzheimer’s disease (AD) pathogenesis will be presented by Zhiqun Tang of the West China…
Nearly 6 million older adults have Alzheimer’s disease in the United States, a number expected to double by 2050. Already the sixth leading cause of…
People who received at least one influenza vaccine were 40% less likely than their non-vaccinated peers to develop Alzheimer’s disease over the course of four…
Many of us will have likely heard of music therapy and art therapy—but what about “travel therapy?”
More than 55 million people worldwide are believed to be living with dementia, according to the World Health Organization. And women are likely to be…
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia, affecting more than 5.8 million individuals in the U.S. Scientists…
Research led by UNSW Sydney’s Center for Healthy Brain Aging (CHeBA) has confirmed treating symptoms of depression is most effective when a non-pharmacological approach is…